Netherlands· NL-e307479cfabc

Ultravist-240 mg/ml, oplossing voor injectie

A iopromide product containing jopromide, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC V08AB05

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about jopromideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Iopromide is registered in 13 of 19 countries.

Countries holding a registration under ATC V08AB05 (iopromide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search iopromide products by name

Iopromide · ATC V08AB05

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Japan
Netherlands
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: JOPROMIDE
Manufacturer: Bayer B.V.
Country: Netherlands (NL)
ATC code: V08AB05
ATC class: Iopromide
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
11408

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

232 interactions on record for iopromide.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check iopromide against other medicines How interaction checks work

Iopromide · interactions on record

232 records

94 severe
55 moderate
83 info

Most severe, free to view

NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe
Amphotericin BA07AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iopromide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iopromide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Ultravist
Belgium · Ultravist
Bulgaria · Ултравист
Cyprus · Ultravist 300, Ultravist 370
Czechia · Ultravist
Germany · Ultravist 300, Ultravist-240
Denmark · Ultravist
Estonia · Ultravist
Spain · Ultravist
France · Ultravist
Greece · Ultravist
Croatia · Ultravist
Hungary · Ultravist
Italy · Ultravist
Lithuania · Ultravist
Luxembourg · Ultravist
Latvia · Ultravist
Malta · Ultravist 370
Norway · Ultravist
Poland · Ultravist 300, Ultravist 370
Portugal · Ultravist 240, Ultravist 300
Romania · Ultravist
Sweden · Ultravist
Slovenia · Ultravist
Slovakia · Ultravist

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e98f12fa-1e6d-472f-8925-e3b123c101ab
GET /v1/drugs/e98f12fa-1e6d-472f-8925-e3b123c101ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11408_smpc.pdf",
  "strength": null,
  "atc_label": "Iopromide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg11408",
  "excipients": [
    "DINATRIUMCALCIUMEDETAAT, GEHYDRATEERD (E 385)",
    "NATRIUMHYDROXIDE (E 524)",
    "TROMETAMOL",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "JOPROMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h11408.pdf",
  "authorised_at": "1987/04/29",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "11408",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about iopromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console